Correction: Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey (The Lancet Global Health (2018) 6(6) (e619–e629), (S2214109X18301864) (10.1016/S2214-109X(18)30186-4));Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey

The Lancet Global Health

Volumn 6, Issue 6, 2018, Pages e619-e629

  Versporten, Ann ^a   Zarb, Peter ^b   Caniaux, Isabelle ^c   Gros, Marie Françoise ^c   Drapier, Nico ^a   Miller, Mark ^c   Jarlier, Vincent ^d,e   Nathwani, Dilip ^f   Goossens, Herman ^a   Koraqi, Andi ^g   Hoxha, Iris ^g   Tafaj, Silva ^g   Lacej, Denada ^g   Hojman, Martin ^g   Quiros, Rodolfo Ernesto ^g   Ghazaryan, Lilit ^g   Cairns, Kelly A ^g   Cheng, Allen ^g   Horne, Kylie C ^g   Doukas, Fiona F ^g   Gottlieb, Thomas ^g   Alsalman, Jameela ^g   Magerman, Koen ^g   Marielle, Gounongbe YT ^g   Ljubovic, Amela Dedeic ^g   Coelho, André Afonso Machado ^g   Gales, Ana Cristina ^g   Keuleyan, Emma ^g   Sabuda, Deana ^g   Boswell, Jennifer Lee ^g   Conly, John M ^g   Rojas, Alvaro ^g   Carvajal, Camila ^g   Labarca, Jaime ^g   Solano, Antonio ^g   Valverde, Carlos Ramírez ^g   Villalobos Vindas, Juan M ^g   Pristas, Irina ^g   Plecko, Vanda ^g   Paphitou, Niki ^g   Shaqiri, Erjona ^g   Rummukainen, Maija Liisa ^g   Pagava, Karaman ^g   Korinteli, Irma ^g   Brandt, Tobias ^g   Messler, Sabine ^g   Enimil, Anthony ^g   Iosifidis, Elias ^g   Roilides, Emmanuel ^g   Sow, Mamadou Saliou ^g   Sengupta, Sharmila ^g   George, Joby V ^g   Poojary, Aruna ^g   Patil, Priyanka ^g   Soltani, Jafar ^g   Jafarpour, Zahra ^g   Ameen, Hadi ^g   Fitzgerald, David ^g   Maor, Yasmin ^g   Chowers, Michal ^g   Temkin, Elizabeth ^g   Esposito, Susanna ^g   Arnoldo, Luca ^g   Brusaferro, Silvio ^g   Gu, Yoshiaki ^g   El Hajji, Feras Darwish ^g   Kim, Nam Joong ^g   Kambaralieva, Baktygul ^g   Pavare, Jana ^g   Zarakauska, Lelde ^g   Usonis, Vytautas ^g   Burokiene, Sigita ^g   Ivaskeviciene, Inga ^g   Mijovic, Gordana ^g   Duborija Kovacevic, Natasa ^g   Bondesio, Kristen ^g   Iregbu, Kenneth ^g   Oduyebo, Oyinlola ^g   Raka, Denis ^g   Raka, Lul ^g   Rachina, Svetlana ^g   Enani, Mushira Abdulaziz ^g   Al Shehri, Mohamed ^g   Carevic, Biljana ^g   Dragovac, Gorana ^g   Obradovic, Dusanka ^g   Stojadinovic, Aleksandra ^g   Radulovic, Lili ^g   Wu, Jia EN ^g   Wei Teng Chung, Gladys ^g   Chen, Hui Hiong ^g   Tambyah, Paul Anantharajah ^g   Lye, David ^g   Tan, Sock Hoon ^g   Ng, Tat Ming ^g   Tay, Hui Lin ^g   Ling, Moi Lin ^g   Chlebicki, Maciej Piotr ^g   Kwa, Andrea L ^g   Lee, Winnie ^g   Beović, Bojana ^g   Dramowski, Angela ^g   Finlayson, Heather ^g   Taljaard, Jantjie ^g   Ojeda Burgos, Guillermo ^g   Retamar, Pilar ^g   Lucas, Johan ^g   Pot, Wolter ^g   Verduin, Cees ^g   Kluytmans, Jan ^g   Scott, Michael ^g   Aldeyab, Mamoon A ^g   McCullagh, Bernadette ^g   Gormley, Cairine ^g   Sharpe, David ^g   Gilchrist, Mark ^g   Whitney, Laura ^g   Laundy, Matthew ^g   Lockwood, Debbie ^g   Drysdale, Simon B ^g   Boudreaux, Jennifer ^g   Septimus, Edward J ^g   Greer, Nickie ^g   Gawrys, Gerard ^g   Rios, Edgar ^g   May, Suzanne ^g   more..

^a UNIVERSITY OF ANTWERP   (Belgium)

^b MATER DEI HOSPITAL   (Malta)

^c BIOMÉRIEUX   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f UNIVERSITY OF DUNDEE   (United Kingdom)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE INHIBITOR; CARBAPENEM; CEPHALOSPORIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BONE MARROW TRANSPLANTATION; CROSS-SECTIONAL STUDY; DATA ANALYSIS; DRUG SURVEILLANCE PROGRAM; FEMALE; HEALTH CARE SURVEY; HEALTHCARE ASSOCIATED INFECTION; HEMATOLOGY; HOSPITAL PATIENT; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL INTENSIVE CARE UNIT; MIDDLE INCOME GROUP; NEONATAL INTENSIVE CARE UNIT; OBSERVATIONAL STUDY; ONCOLOGY; PATIENT CHARACTERISTICS; PATIENT COMPLIANCE; PEDIATRIC INTENSIVE CARE UNIT; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL INTENSIVE CARE UNIT; GLOBAL HEALTH; HOSPITAL; HOSPITALIZATION; INTERNET; PREVALENCE; STATISTICS AND NUMERICAL DATA;

ADULT; ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, MICROBIAL; FEMALE; GLOBAL HEALTH; HEALTH CARE SURVEYS; HOSPITALIZATION; HOSPITALS; HUMANS; INTERNET; MALE; PREVALENCE;

EID: 85045914218     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(18)30347-4     Document Type: Erratum

References (37)

1. MacDougall, C, Polk, RE, Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev 18 (2005), 638–656.
2. Harbarth, S, Balkhy, HH, Goossens, H, et al. Antimicrobial resistance: one world, one fight!. Antimicrob Resist Infect Control, 4, 2015, 49.
3. WHO, Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2016-2017. http://apps.who.int/iris/bitstream/10665/259744/1/9789241513449-eng.pdf?ua=1, Feb 7, 2018. (Accessed 7 February 2018)
4. Barlam, TF, Cosgrove, SE, Abbo, LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 62 (2016), e51–e77.
5. Davey, P, Marwick, CA, Scott, CL, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev, 2, 2017, CD003543.
6. Schuts, EC, Hulscher, MEJL, Mouton, JW, et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis 16 (2016), 847–856.
7. BioMérieux, International experts join forces against superbugs at the 4th World Forum on Healthcare-Associated Infections and Antimicrobial Resistance. http://www.biomerieux.com/en/4th-world-forum-healthcare-associated-infections-and-antimicrobial-resistance, Feb 7, 2018. (Accessed 7 February 2018)
8. Ansari, F, Erntell, M, Goossens, H, et al. The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis 49 (2009), 1496–1504.
9. Zarb, P, Amadeo, B, Muller, A, et al. Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC point prevalence survey 2009. J Antimicrob Chemother 66 (2011), 443–449.
10. Zarb, P, Goossens, H, European Surveillance of Antimicrobial Consumption (ESAC): value of a point-prevalence survey of antimicrobial use across Europe. Drugs 71 (2011), 745–755.
11. Malcolm, W, Nathwani, D, Davey, P, et al. From intermittent antibiotic point prevalence surveys to quality improvement: experience in Scottish hospitals. Antimicrob Resist Infect Control, 2, 2013, 3.
12. Pristas, I, Barsic, B, Butic, I, et al. Point prevalence survey on antibiotic use in a Croatian infectious disease hospital. J Chemother 25 (2013), 222–228.
13. Zarb, P, Coignard, B, Griskeviciene, J, et al. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill, 17, 2012, 20316.
14. Versporten, A, Sharland, M, Bielicki, J, et al. The antibiotic resistance and prescribing in European children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide. Pediatr Infect Dis J 32 (2013), e242–e253.
15. Versporten, A, Bielicki, J, Drapier, N, et al. The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children. J Antimicrob Chemother 71 (2016), 1106–1117.
16. Lestner, JM, Versporten, A, Doerholt, K, et al. Systemic antifungal prescribing in neonates and children: outcomes from the Antibiotic Resistance and Prescribing in European Children (ARPEC) Study. Antimicrob Agents Chemother 59 (2015), 782–789.
17. De, LM, Dona, D, Montagnani, C, et al. Antibiotic prescriptions and prophylaxis in Italian children. Is it time to change? Data from the ARPEC project. PLoS One, 11, 2016, e0154662.
18. UN Statistics Division, Standard country and area codes for statistical use. http://unstats.un.org/unsd/methods/m49/m49.htm, Feb 7, 2018. (Accessed 7 February 2018)
19. European Centre for Disease Prevention and Control, Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/0512-TED-PPS-HAI-antimicrobial-use-protocol.pdf, Feb 7, 2018. (Accessed 7 February 2018)
20. WHO Collaborating Centre for Drug Statistics Methodology, Anatomical Therapeutic Chemical (ATC) classification system: guidelines for ATC classification and DDD assignment. http://www.whocc.no/, Feb 7, 2018. (Accessed 7 February 2018)
21. European Centre for Disease Prevention and Control, Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals; 2011–2012. https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/healthcare-associated-infections-antimicrobial-use-PPS.pdf, April 11, 2018. (Accessed 11 April 2018)
22. Magill, SS, Edwards, JR, Beldavs, ZG, et al. Prevalence of antimicrobial use in US acute care hospitals, May–September 2011. JAMA 312 (2014), 1438–1446.
23. Guzman-Blanco, M, Mejia, C, Isturiz, R, et al. Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Latin America. Int J Antimicrob Agents 34 (2009), 304–308.
24. Guzman-Blanco, M, Labarca, JA, Villegas, MV, et al. Extended spectrum beta-lactamase producers among nosocomial Enterobacteriaceae in Latin America. Braz J Infect Dis 18 (2014), 421–433.
25. Maya, JJ, Ruiz, SJ, Blanco, VM, et al. Current status of carbapenemases in Latin America. Expert Rev Anti Infect Ther 11 (2013), 657–667.
26. Kang, CI, Song, JH, Antimicrobial resistance in Asia: current epidemiology and clinical implications. Infect Chemother 45 (2013), 22–31.
27. Pollack, LA, Plachouras, D, Sinkowitz-Cochran, R, et al. A concise set of structure and process indicators to assess and compare antimicrobial stewardship programs among EU and US hospitals: results from a multinational expert panel. Infect Control Hosp Epidemiol 37 (2016), 1201–1211.
28. Shrayteh, ZM, Rahal, MK, Malaeb, DN, Practice of switch from intravenous to oral antibiotics. Springerplus, 3, 2014, 717.
29. Zhang, L, Huang, Y, Zhou, Y, et al. Antibiotic administration routes significantly influence the levels of antibiotic resistance in gut microbiota. Antimicrob Agents Chemother 57 (2013), 3659–3666.
30. Novak, MT, Kotanen, CN, Carrara, S, et al. Diagnostic tools and technologies for infectious and non-communicable diseases in low-and-middle-income countries. Health Technol 3 (2013), 271–281.
31. MacVane, SH, Hurst, JM, Steed, LL, The role of antimicrobial stewardship in the clinical microbiology laboratory: stepping up to the plate. Open Forum Infect Dis, 3, 2016, ofw201.
32. De, WK, Allerberger, F, Amann, S, et al. Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases. Infection 44 (2016), 395–439.
33. Hagel, S, Scheuerlein, H, Perioperative antibiotic prophylaxis and antimicrobial therapy of intra-abdominal infections. Viszeralmedizin 30 (2014), 310–316.
34. Bratzler, DW, Houck, PM, Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 38 (2004), 1706–1715.
35. Ivers, N, Jamtvedt, G, Flottorp, S, et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev, 6, 2012, CD000259.
36. Federal Public Health Service Health, Food Chain Safety and Environment, Belgian Antibiotic Policy Coordination Committee. http://consultativebodies.health.belgium.be/en/advisory-and-consultative-bodies/commissions/BAPCOC, Feb 7, 2018. (Accessed 7 February 2018)
37. Ibrahim, OM, Polk, RE, Benchmarking antimicrobial drug use in hospitals. Expert Rev Anti Infect Ther 10 (2012), 445–457.